PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 39 filers reported holding PREVAIL THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,730,000 | +126.4% | 75,000 | 0.0% | 0.52% | +107.7% |
| Q3 2020 | $764,000 | -31.7% | 75,000 | 0.0% | 0.25% | -23.2% |
| Q2 2020 | $1,118,000 | +22.3% | 75,000 | 0.0% | 0.32% | -15.2% |
| Q1 2020 | $914,000 | -23.0% | 75,000 | 0.0% | 0.38% | -6.4% |
| Q4 2019 | $1,187,000 | +28.9% | 75,000 | 0.0% | 0.41% | +17.6% |
| Q3 2019 | $921,000 | -7.0% | 75,000 | 0.0% | 0.35% | -7.0% |
| Q2 2019 | $990,000 | – | 75,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|